Excel Industries Ltd

Excel Industries Ltd

$EXCELINDUSSpecialty ChemicalsNSEBSE

Excel Industries Ltd (EXCELINDUS) last traded at ₹1,057, a market capitalisation of ₹1,329 crore, on a P/E of 18.6. Over the past 52 weeks the stock has ranged between ₹800 and ₹1,265. Excel Industries Ltd last reported results for the quarter ended Jun 2026, with sales of ₹294 crore and net profit of ₹29 crore. Excel Industries Ltd’s annual general meeting is scheduled for 24 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Excel Industries Ltd share price and key metrics

Current price
₹1,057
Market cap
₹1,329 cr
Stock P/E
18.6
Book value
₹1,355
ROE
4.60%
ROCE
6.06%
Dividend yield
1.30%
52w high / low
1265/800

Metrics as of 25 Aug 2026. Not real time.

Excel Industries Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹294 cr, down 5.2% from ₹310 cr a year earlier. Net profit was ₹29 cr, down 14.7% year on year.

Excel Industries Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales269196248310270234281294
Expenses220184228267240218259251
Operating profit4912204230162242
OPM %18%6%8%14%11%7%8%14%
Other income856127537
Interest10011001
Depreciation9999991010
Profit before tax478164427111539
Tax %24%26%24%24%23%25%16%24%
Net profit36612342181229
EPS (₹)28.384.939.8726.8616.866.719.7723.44

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Excel Industries Ltd annual results

Excel Industries Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales7491,1781,0908269781,0951,079
Operating profit12223212925121110110
OPM %16%20%12%3.0%12%10%10%
Net profit711618017857671
EPS (₹)56.55128.2363.5913.5367.8660.2056.78

TTM is the trailing twelve months to the most recent quarter.

Excel Industries Ltd growth and returns

Compounded Sales Growth
10 Years
9%
5 Years
8%
3 Years
0%
TTM
5%
Compounded Profit Growth
10 Years
11%
5 Years
1%
3 Years
-2%
TTM
-19%
Stock Price CAGR
10 Years
13%
5 Years
-1%
3 Years
5%
1 Year
-14%
Return on Equity
10 Years
9%
5 Years
6%
3 Years
4%
Last Year
5%

Excel Industries Ltd shareholding pattern

Promoters held 51.86% at Jun 2026, down from 52.68% at Jun 2025. FIIs 1.85% and DIIs 7.08%.

Excel Industries Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters52.56%52.57%52.66%52.68%52.68%52.69%52.69%51.86%
FIIs1.56%2.17%2.05%2.08%2.01%2.01%1.94%1.85%
DIIs6.97%7.00%6.98%6.98%7.06%7.07%7.07%7.08%
Public38.91%38.26%38.32%38.27%38.27%38.25%38.31%39.22%
No. of shareholders22,97922,44822,82022,29722,59322,08421,70321,439

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

When is Excel Industries Ltd’s AGM?

Excel Industries Ltd’s annual general meeting is scheduled for 24 Sept 2026.

  • AGMSixty Fifth Annual General Meeting

See the full results calendar for every Indian company reporting in the next 30 days.

Excel Industries Ltd corporate filings

  • Pursuant to Regulation 47 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the copies of the Free Press Journal (English) and Navshakti (Marathi) ....Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Excel Industries Ltd has published notices in the Free Press Journal (English) and…

    Read the full analysis
  • Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we enclose herewith the Investor Presentation of the Unaudited Financial Results for the quarter ended June 30, 2026. The ....Company Updatemedium impact
    Filing PDF

    Cruxal's analysis: Excel Industries Limited reported Q1 FY27 standalone revenue of 294 crore, reaching…

    Read the full analysis
  • We refer to our letter dated 13th August, 2026, informing about the Company''s Unaudited Financial Results for the quarter ended 30th June, 2026. In this connection and pursuant to Regulation ....Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Excel Industries Limited has published its unaudited financial results for the quarter…

    Read the full analysis
  • This is to inform you that Thursday, 17th September, 2026 has been fixed as the Record Date for the purpose of determining the shareholders of the Company who would be entitled for Final ....Corp. Actionlow impact
    Filing PDF

    Cruxal's analysis: Excel Industries has announced Thursday, 17th September, 2026 as the Record Date to…

    Read the full analysis
  • This is to inform you that the Sixty Fifth Annual General Meeting of the Member of the Company will be held on Thursday, 24th of September, 2026 at 03:00 p.m. through Video Conferencing ....AGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Excel Industries Ltd. has formally announced that its 65th Annual General Meeting (AGM)…

    Read the full analysis
  • Pursuant to Regulation 33 of SEBI(LODR)Regulations, 2015, we hereby inform you that at the meeting of the Board of Directors of the Company held today, the Board has approved unaudited ....Resulthigh impact
    Filing PDF

    Cruxal's analysis: Excel Industries Limited reported standalone revenue from operations of 293.83 crore for…

    Read the full analysis
  • Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that at the meeting of the Board of Directors of the Company ....Board Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Excel Industries Limited reported standalone revenue from operations of 293.73 crore for…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Excel Industries Ltd

Cruxal reads every Excel Industries Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.